comparemela.com

Latest Breaking News On - Pear therapeutics company profile get rating - Page 1 : comparemela.com

Pear Therapeutics, Inc (NASDAQ:PEAR) Sees Large Decrease in Short Interest

Pear Therapeutics, Inc. (NASDAQ:PEAR – Get Rating) saw a significant decrease in short interest during the month of May. As of May 31st, there was short interest totalling 1,150,000 shares, a decrease of 19.6% from the May 15th total of 1,430,000 shares. Based on an average daily volume of 319,800 shares, the days-to-cover ratio is […]

Pear Therapeutics (NASDAQ:PEAR) Stock Rating Reaffirmed by Chardan Capital

Pear Therapeutics (NASDAQ:PEAR – Get Rating)‘s stock had its “buy” rating reiterated by Chardan Capital in a report released on Monday, PriceTargets.com reports. Separately, Citigroup raised their target price on shares of Pear Therapeutics from $10.00 to $11.00 and gave the stock a “buy” rating in a report on Tuesday, May 17th. One equities research […]

Contrasting Pear Therapeutics (NASDAQ:PEAR) and Better Therapeutics (NASDAQ:BTTX)

Pear Therapeutics (NASDAQ:PEAR – Get Rating) and Better Therapeutics (NASDAQ:BTTX – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, dividends, earnings, risk, analyst recommendations, valuation and profitability. Profitability This table compares Pear Therapeutics and Better Therapeutics’ […]

Pear Therapeutics (NASDAQ:PEAR) and Sema4 (NASDAQ:SMFR) Head to Head Review

Sema4 (NASDAQ:SMFR – Get Rating) and Pear Therapeutics (NASDAQ:PEAR – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, dividends, earnings and risk. Valuation & Earnings This table compares Sema4 and Pear Therapeutics’ […]

Head to Head Review: Pear Therapeutics (NASDAQ:PEAR) versus Covalon Technologies (OTCMKTS:CVALF)

Pear Therapeutics (NASDAQ:PEAR – Get Rating) and Covalon Technologies (OTCMKTS:CVALF – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, dividends, earnings and risk. Analyst Recommendations This is a summary of recent ratings […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.